News and events

Press Releases

  • January, 6th 2014

    Topera today announced that it has received 510(k) clearance by the U.S Food and Drug Administration (FDA) for the latest generation of its 3D Mapping System. The workstation will be exhibited at the 19th International AF Symposium in Orlando, January 9-11, 2014. Topera pioneered the field of advanced electrophysiologic mapping with the introduction of our 3D Mapping System...        download

  • November, 25th 2013

    Topera today shared the results of an independent evaluation of its diagnostic system’s ability to improve AF outcomes by identifying of the sources that sustain complex cardiac arrhythmias. The results of the study, “Ablation of Atrial Fibrillation Rotors and Focal Sources Improves Outcome Over Conventional Ablation Alone in Independent Laboratories: Multicenter Validation of Focal Impulse and...        download

  • November, 07th 2013

    Topera today announced the 510(k) clearance by the U.S. Food and Drug Administration (FDA) for the FIRMap Catheter and its U.S. commercial availability. “Securing the FDA clearance to offer our panoramic diagnostic catheter with our next generation 3D mapping system so soon after receiving International CE Marks is an important milestone for Topera.        download

  • April, 30th 2013

    Topera today announced that its FDA-cleared RhythmView 3D mapping workstation will be discussed in 21 scientific presentations at the 34th Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 8-11 in Denver, CO. The presentations will provide clinicians with additional information about the electrical sources that        download

  • April, 25nd 2013

    Topera today announced it has completed a $25 million Series C financing round. The round was led by new investor New Enterprise Associates (NEA) with the participation of a new strategic industry partner along with existing investors and the company’s management team.        download

  • November, 2nd 2012

    Topera today announced that its RhythmView™ 3D Electrophysiological Mapping System will be featured in 8 presentations at the 2012 American Heart Association Scientific Sessions, November 3-7 in Los Angeles, CA.        download

  • June 15th, 2012

    Topera today announced that its RhythmView™ 3D Electrophysiological Mapping System will be featured in 11 scientific presentations at Cardiostim 2012, the 18th WORLD CONGRESS on Cardiac EP & Cardiac Techniques, June 13-16 in Nice, France.

  • June 7th, 2012

    World-renowned scientist and cardiologist Karl-Heinz Kuck, MD, has been appointed Chair of the company’s International Scientific Advisory Board. Author of more than 450 scientific papers, Professor Kuck has served as a board member of the European Heart Rhythm Association (EHRA) for the past four years and is the current EHRA president-elect.

  • May 10th, 2012

    The initial independent clinical cases evaluation of the RhythmView system show clinicians were enabled to identify in all patients the sources of AF, such as rotors and focal beats.                              

  • May 4th, 2012

    Our RhythmView™ System is being featured in 16 presentations at the Heart Rhythm Society 2012 Scientific Sessions.                              

  • February 29th, 2012

    Topera Medical, a developer of innovative mapping systems that help identify the electrical source of cardiac arrhythmias, will present at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5th 2012
                                  

  • November 23rd, 2011

    Topera Medical, a developer of innovative mapping systems that help identify the electrical source of cardiac arrhythmias, has been selected for a presentation and panel discussion on December 1, 2011 at the Bank of America Merrill Lynch Cardiovascular Device Innovation Day: A Look at Four Potentially Disruptive Innovations in Cardiovascular Devices. This event will be held at the Bank of America Merrill Lynch Offices at One Bryant Park in New York.

  • November 22nd, 2011

    Topera Medical, a developer of innovative mapping systems that help identify the electrical source of cardiac arrhythmias, is scheduled to participate in the Piper Jaffray 23rd Annual Healthcare Conference at The New York Palace on November 29, 2011 in New York.

  • October 10th, 2011

    Topera Medical, a developer of innovative mapping systems that help identify the electrical source of cardiac arrhythmias, today announced that Clinical and Healtheconomic data resulting from the clinical use of their RhythmView™ diagnostic system will be presented during the 12th International Workshop on Cardiac Arrhythmias - VeniceArrhythmias 2011 - which will take place in Venice, Italy from 9-12 October 2011.

  • October 4th, 2011

    Topera Medical, announces the appointment of Melissa Walker, MS, RAC, FRAPS as Senior Vice President of Regulatory, Quality and Clinical Affairs. Walker will be responsible for various European and U.S. Food and Drug Administration (FDA) regulatory submissions, regulatory compliance, as well as the company's quality system and clinical affairs strategy.

  • May 4th, 2011

    Topera Medical announces that the basic technology used in its RhythmViewTM diagnostic product will be featured in 12 scientific presentations at the 32nd Annual Scientific Sessions of the Heart Rhythm Society (HRS), May 4-7 in San Francisco. The clinical presentations will provide clinicians with new information about the electrical source of cardiac arrhythmias.

  • March 30th, 2011

    Topera Medical proudly announces the addition of Dr. Eric Prystowsky, MD, FHRS, to the company's Management Advisory Board. Topera Medical CEO Edward Kerslake, Ph.D., commented: “We're thrilled and honored to have him join our Advisory Board. Dr. Prystowsky is a world-renowned electrophysiologist who has influenced the development and adoption of numerous innovative tools and techniques used by electrophysiologists today”.

  • March 24th, 2011

    Topera Medical announces the creation of its Scientific Advisory Board (SAB).                                             

  • March 24th, 2011

    Topera Medical announces the formation and initial appointments to its Management Advisory Board, comprised of established leaders in the medical device industry. With multi-disciplinary backgrounds, the Management Advisory Board will support Topera Medical's growth strategy and achieve its business objectives.